SCHEMBL4239340

SCHEMBL4239340

O=C(O)c1c(CI)cnn1C(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.31

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.31
NPC1 O15118 2/20 0.31
TP53 P04637 2/20 0.31
RAB9A P51151 2/20 0.31
TSHR P16473 2/20 0.31
LMNA P02545 1/20 0.31
GAA P10253 1/20 0.31
PKM P14618 1/20 0.31
HPGDS O60760 1/20 0.30
ALKBH2 Q6NS38 1/20 0.30
CYP2C19 P33261 1/20 0.30
HIF1A Q16665 1/20 0.30
KDM4E B2RXH2 1/20 0.30
ALDH1A1 P00352 1/20 0.30
HPGD P15428 1/20 0.30
NR4A3 Q92570 1/20 0.30
POLB P06746 1/20 0.30
MAPT P10636 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4296452 0.83 HPGD (0.44) SMN1; SMN2NPC1TP53RAB9ATSHR
SCHEMBL5367157 0.75 ALDH1A1 (0.34) SMN1; SMN2TSHRKDM4EALDH1A1POLB
SCHEMBL27815920 0.68 ALDH1A1 (0.34) SMN1; SMN2TSHRGAAPKMCYP2C19
SCHEMBL12042936 0.66 CYP11B1 (0.32)
SCHEMBL285565 0.66 KDM4E (0.42) SMN1; SMN2NPC1TP53RAB9ATSHR
SCHEMBL27815929 0.65 GRN (0.37) SMN1; SMN2LMNAGAAKDM4EALDH1A1
SCHEMBL5361990 0.65 CYP11B1 (0.37) SMN1; SMN2TP53RAB9ATSHRLMNA
SCHEMBL7540410 0.62 ATM (0.36) SMN1; SMN2NPC1TP53RAB9ACYP2C19
SCHEMBL8387760 0.62 CYP11B1 (0.36) TSHRKDM4EALDH1A1HPGDPOLB
SCHEMBL27761434 0.62 KDM4E (0.33) SMN1; SMN2TSHRKDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009119880-A1 SUBSTITUTED PYRAZOLE DERIVATIVES AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-10-01 WO disclosed